Atlas Trials

Ocugen

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ocugen

RecordFirmDate
Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD (NCT07770828)Ocugen2026-08-11
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa (NCT06388200)Ocugen2024-06-18
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) (NCT05802329)Ocugen2024-01-13
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease (NCT05956626)Ocugen2023-08-25
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy (NCT06018558)Ocugen2023-02-23
Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults (NCT05258669)Ocugen2022-02-20
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis (NCT05203939)Ocugen2022-01-24
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease (NCT03591874)Ocugen2018-12-23
Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) (NCT03785340)Ocugen2018-12-03
Dry Eye Disease Study With Brimonidine (NCT03418727)Ocugen2017-09-06

Track Ocugen automatically

Every clearance here is in the API, with alerts when new ones post.